Absence seizures, atypical absence seizures (adjunct) and myoclonic seizures in adults and children.
RAG rating
Amber initiation
Document type
Primary Care prescribing resource
Hertfordshire and West Essex ICB
Output type
Pharmacy / Prescribing

Ethosuximide capsules

Dear Patient

The NHS carries out regular reviews of medicines to make sure that patients continue to receive high quality and effective treatment that costs the NHS less.

The latest review involves a change in one of the medications for epilepsy on your prescription. The full details of the change are shown below. This new medication will be given to you when you collect your next repeat prescription.


WHAT IT WILL CHANGE TO: Emeside® 250mg capsule

This new medicine contains the same active ingredient as your old medication so please continue to take it in the same way and at the same dose as before.

Please finish using all the medicine you currently have before starting on the new Emeside® capsules. The new medicine contains soya and will not be suitable for you if you have an allergy to soya or have been told to avoid soya. Contact your GP surgery if you have any concerns. You may already be receiving this brand from your pharmacy as it is often supplied by pharmacies when a brand is not specified on a prescription.

You should notice no difference in how the new version of your medicine works for your epilepsy as it is equally effective and has the same side effects as your old version

We would also like to take this opportunity to remind you to order only the medicines you need whenever you submit your repeat prescription request.

If you are concerned or wish to discuss the matter, please do not hesitate to contact the practice.

Yours sincerely

Version number
Developed by
Approved by
Date approved / updated
December 2022
Review date
The recommendation is based upon the evidence available at the time of publication. This recommendation will be reviewed upon request in the light of new evidence becoming available.
Superseded version